Abortion in Canada 2026
Canada is one of only a handful of countries in the world that operates with no federal criminal law restricting abortion at any stage of pregnancy — a legal reality that has been in place since the Supreme Court of Canada’s R. v. Morgentaler ruling on January 28, 1988, which struck down the existing abortion law as a violation of the Charter right to security of the person. No replacement federal legislation has ever been passed in the nearly four decades since. Abortion is regulated and funded as a standard medical procedure under provincial and territorial health insurance plans, covered at no direct cost to patients holding a valid provincial health card. The Canadian Institute for Health Information (CIHI) — the authoritative national source — published its most recent abortion data on March 20, 2025, covering the full calendar year 2023. That release confirmed 101,553 reported induced abortions in Canada in 2023, up from 97,211 in 2022, representing a 4.5% year-over-year increase and the first time the annual total had crossed 100,000 since 2015 — also making it the highest reported total in the past ten years. The national abortion rate in 2023 was 11.1 per 1,000 women aged 15–49, essentially unchanged from 2022, confirming that while absolute volumes rose due largely to rapid population growth, the underlying per-capita rate has stabilized.
The most significant story in Canadian abortion in 2026 is not the headline number — it is the transformation in how abortions are accessed, and the persistent, well-documented gaps in access that remain despite a uniquely permissive legal framework. The introduction of Mifegymiso — the Canadian brand name for the mifepristone-misoprostol combination medication, approved by Health Canada in 2015 and available through pharmacies from 2017 — has fundamentally reshaped abortion care. Medical abortion’s share of all reported abortions rose from under 4% before 2017 to 41.3% in 2023, and a landmark CMAJ study published April 7, 2025 found that abortion access in Ontario rose from 37% of the population having a local service in 2017 to 91% in 2022 — almost entirely driven by pharmacy dispensation of the pill. Yet surgical abortion clinics are closing: Vancouver’s Elizabeth Bagshaw Clinic, open 35 years, announced closure on March 29, 2025. New Brunswick’s only non-hospital surgical abortion clinic closed in January 2024, and while Premier Susan Holt repealed the funding ban on non-hospital procedural abortions on November 7, 2024, as of November 2025 the same three hospitals remain the only sites offering the procedure in the province. The CBC reported on February 12, 2026 that Quebec’s Mifegymiso prescriptions jumped nearly 80% in 2025 vs 2024 — a powerful sign that the medication abortion revolution is still accelerating even as surgical access is contracting nationwide.
Interesting Facts About Abortion in Canada 2026
Here are the most important, completely verified facts about abortion in Canada as of March 2026 — drawn exclusively from CIHI, Health Canada, CBC, CMAJ, PMC, Statistics Canada, and peer-reviewed research published in 2024–2026.
| # | Fact | Data Point |
|---|---|---|
| 1 | Total reported induced abortions in Canada — 2023 (CIHI, March 20, 2025) | 101,553 |
| 2 | Total reported induced abortions in Canada — 2022 | 97,211 |
| 3 | Year-over-year increase (2022 to 2023) | +4,342 (+4.5%) |
| 4 | First time annual total crossed 100,000 since | 2015 |
| 5 | Highest reported total in the past | 10 years |
| 6 | National abortion rate in 2023 (per 1,000 women aged 15–49) | 11.1 |
| 7 | Ontario abortions in 2023 (Ontario Ministry of Health) | 52,467 |
| 8 | Quebec abortions in 2023 (CIHI) | ~22,766 |
| 9 | Abortions in hospitals in 2023 | 20.8% — down from 46.3% in 2008 |
| 10 | Abortions in non-hospital settings in 2023 | 79.2% |
| 11 | Surgical abortions (2023) | 58.7% of total |
| 12 | Medical abortions via pill (2023) | 41.3% of total — up from 39.5% in 2022 |
| 13 | Medical abortion share before Mifegymiso (pre-2017) | Under 4% |
| 14 | Ontario abortion access rose from 37% (2017) to 91% (2022) | After Mifegymiso pharmacy dispensing — CMAJ, April 7, 2025 |
| 15 | Mifegymiso share of Ontario abortions in 2022 | 56% |
| 16 | Mifegymiso share of Quebec abortions in 2022 | Only 17% |
| 17 | Quebec Mifegymiso prescriptions in 2025 vs 2024 | 2,852 vs 1,586 — +80% (CBC, February 12, 2026) |
| 18 | New Brunswick — Mifegymiso share of all abortions (2024) | Over 70% |
| 19 | Age group with most abortions in 2023 | 25–29 years — ~25,677 abortions |
| 20 | Abortion rate — women aged 25–29 (2023) | 18.4 per 1,000 women |
| 21 | Abortion rate — women aged 30–34 (2023) | 15.4 per 1,000 women |
| 22 | Abortion rate — women aged 18–24 (2023) | 14.9 per 1,000 women |
| 23 | Abortion rate — girls aged 15–17 (2023) | 3.3 per 1,000 — lowest |
| 24 | Elizabeth Bagshaw Clinic (Vancouver) — announced closure | March 29, 2025 — after 35+ years |
| 25 | NB ban on funding non-hospital surgical abortions — repealed | November 7, 2024 by Premier Holt |
| 26 | One year after NB policy change — still only | 3 hospitals in 2 cities offering surgical abortion (November 2025) |
| 27 | Mifegymiso Health Canada approved gestational limit | 9 weeks (63 days) |
| 28 | Canada’s abortion law since 1988 | No federal criminal restrictions — any gestational age |
| 29 | Population growth of women aged 15–49 (2022 to 2023) | Grew by ~400,000 — main driver of rising absolute volumes |
| 30 | CIHI data coverage note | Some ongoing underestimation — incomplete physician billing in all jurisdictions |
Source: Canadian Institute for Health Information (CIHI), Induced Abortions Reported in Canada in 2023, March 20, 2025; Ontario Ministry of Health and Long-Term Care 2023 data; CMAJ, “Changes in local access to mifepristone dispensed by community pharmacies for medication abortion in Ontario,” April 7, 2025
These 30 facts define the state of abortion in Canada with unusual precision heading into 2026. The 101,553 reported abortions in 2023 are the headline number, but the most structurally significant data point is the shift from under 4% medical abortion before 2017 to 41.3% in 2023 — a transformation driven entirely by a single regulatory change that allowed pharmacists to dispense Mifegymiso. The Quebec 80% jump in Mifegymiso prescriptions in 2025 from CBC’s February 12, 2026 report — from 1,586 in 2024 to 2,852 in 2025 — is the clearest available evidence that this transformation is still accelerating. Yet the Vancouver Elizabeth Bagshaw Clinic closure on March 29, 2025, the continued presence of only three hospitals in two New Brunswick cities offering surgical abortion a full year after the province’s landmark policy change, and the fact that fewer than 17% of Canadian hospitals perform abortions at all, confirm that the structural access gap between what the law permits and what geography and infrastructure actually deliver remains very real.
Canada Abortion Volume Statistics in 2026 | Annual Totals and Trend 2019–2023
The most authoritative source on how many abortions occur annually in Canada is CIHI’s annual data release. The most recent covers 2023, published March 20, 2025. The next release — expected to cover 2024 — had not been published as of March 17, 2026.
| Year | Reported Induced Abortions (Canada) | Year-over-Year Change | Key Note |
|---|---|---|---|
| 2019 | 83,576 | — | Lowest reported since 1989 |
| 2020 | 91,551 | +9.5% | CIHI enhanced methodology introduced |
| 2021 | 87,485 | –4.4% | Pandemic effects; methodology change |
| 2022 | 97,211 | +11.1% | Post-pandemic recovery |
| 2023 | 101,553 | +4.5% | 10-year high; first >100,000 since 2015 |
| Ontario only (2023) | 52,467 (OMHLTC) | +2,793 vs 2022 | Higher than CIHI Ontario count |
| Quebec only (2023) | ~22,766 (CIHI) | — | Largest Quebec total in recent years |
| National abortion rate (2023) | 11.1 per 1,000 women aged 15–49 | Same as 2022 | Population growth drove volume, not rate |
| Women aged 15–49 in Canada (2022 to 2023) | Grew by ~400,000 | Immigration-driven | Main factor in rising absolute volumes |
| 2024 data status | Not yet released by CIHI | Expected March 2026 | Not available as of March 17, 2026 |
Source: Canadian Institute for Health Information, Induced Abortions Reported in Canada in 2023, March 20, 2025; Ontario Ministry of Health and Long-Term Care annual abortion data 2023; We Need a Law analysis of CIHI 2023 data, April 2025; ARCC Statistics — Abortion in Canada, updated June 2025
The 101,553 total in 2023 is the most current definitive national figure and deserves careful context. The volume increased by over 4,300 from 2022 to 2023, yet the abortion rate per 1,000 women stayed at 11.1 — meaning the rise was almost entirely explained by Canada’s rapid population growth, not a change in the underlying likelihood of any individual seeking an abortion. Canada’s population of women aged 15–49 grew by nearly 400,000 between 2022 and 2023 alone, driven by record immigration levels, and even a perfectly flat per-capita rate will produce more absolute abortions when the denominator is growing that fast. CIHI itself cautions that its figures represent a documented underestimate: the enhanced methodology introduced in 2020–2021 — which added physician billing data for five provinces — captures abortions in doctors’ offices, by nurse practitioners, and in non-hospital community clinics that were previously invisible, but this enhanced methodology has not yet been applied to all provinces. Ontario’s own Ministry of Health count of 52,467 abortions for 2023 significantly exceeds what CIHI captures for Ontario in its national tables, the clearest evidence that the real national total is higher than 101,553.
The trend since 2019 shows both volatility and a clear upward direction. The 2019 low of 83,576 reflected real-terms declines in abortion rates, particularly among younger women, that researchers link to improved long-acting contraceptive access and changing sexual behaviour patterns. The jump in 2020 was partly methodological (enhanced reporting). The 2021 dip reflected genuine pandemic-era patterns. The 2022 and 2023 increases reflect a combination of population growth, improved access through Mifegymiso, and possible shifts in contraceptive use patterns tracked in the Ontario-focused PMC study published April 2025. Researchers found that abortion rates in Ontario gradually increased from 2017 as mifepristone became widely available, with the most significant increase among women aged 20–24 (rate difference of +4.2 per 1,000 versus pre-mifepristone trends). The next CIHI annual data release — expected to cover 2024 — will be the first to show whether the 2023 crossing of the 100,000 mark was a one-year event or the beginning of a new baseline.
Canada Abortion Method Statistics in 2026 | Medical vs. Surgical 2022–2023
The method by which abortions are performed in Canada has undergone a fundamental transformation since Mifegymiso’s introduction in 2017 — and the 2023 CIHI data captures this ongoing shift in precise detail.
| Method / Setting | 2022 | 2023 | Change |
|---|---|---|---|
| Surgical abortions (% of total) | 63.2% | 58.7% | –4.5 percentage points |
| Medical abortions — pill (% of total) | 39.5% | 41.3% | +1.8 percentage points |
| Medical abortion share before Mifegymiso (pre-2017) | — | — | Under 4% |
| Hospital setting (% of all abortions, 2023) | — | 20.8% | Down from 46.3% in 2008 |
| Non-hospital setting (% of all abortions, 2023) | — | 79.2% | Up from 53.7% in 2008 |
| Ontario — Mifegymiso share of abortions (2022) | 56% | — | Up from ~8% in 2017 |
| Quebec — Mifegymiso share of abortions (2022) | 17% | — | Below national average |
| New Brunswick — Mifegymiso share of all abortions (2024) | — | — | Over 70% |
| Quebec Mifegymiso prescriptions reimbursed (2024) | — | — | 1,586 people |
| Quebec Mifegymiso prescriptions reimbursed (2025) | — | — | 2,852 people (+80%) |
| Ontario abortion access (local service) — 2017 vs 2022 | 37% → 91% | — | CMAJ study, April 7, 2025 |
| Ontario surgical abortion access — 2017 vs 2022 | 22% → 18% | — | Declined as medical access rose |
| Mifegymiso Health Canada gestational limit | — | — | 9 weeks (63 days) |
Source: CIHI, Induced Abortions Reported in Canada in 2023, March 20, 2025; CMAJ study “Changes in local access to mifepristone,” April 7, 2025; CBC News Quebec RAMQ data, February 12, 2026; CBC News New Brunswick, November 7, 2024; We Need a Law CIHI analysis, April 2025; Global News, April 7, 2025
The 4.5 percentage point decline in surgical abortion share — from 63.2% in 2022 to 58.7% in 2023 — is the most structurally important data point in this table, and its trajectory points unmistakably to a near-future Canadian abortion landscape where medical abortion becomes the dominant method. The CMAJ study published April 7, 2025, representing the first evidence-based assessment of how Mifegymiso access changed abortion services across Ontario, found that the proportion of people with a local abortion service in the province went from 37% to 91% in five years — almost entirely because pharmacies became able to fill Mifegymiso prescriptions. In 2022, 56% of Ontario abortions were medical, the highest provincial share in the country. The contrast with Quebec at only 17% in the same year is stark, and reflects both the historically more restrictive prescribing rules from the College des Médecins du Québec and the province’s dense network of established surgical abortion clinics — which historically made surgical access relatively good. The 80% jump in Quebec Mifegymiso prescriptions in 2025 vs 2024, confirmed by CBC using data from the Quebec public health insurance board (RAMQ) on February 12, 2026, suggests these provincial patterns are now rapidly converging.
The growing dominance of non-hospital settings — from 53.7% in 2008 to 79.2% in 2023 — tells a parallel story. The abortion pill can be prescribed by a family doctor or nurse practitioner, filled at a pharmacy, and taken at home, requiring no clinic or hospital visit at all. This is simultaneously the biggest advance in abortion access in Canadian history and a structural risk: as the need for dedicated abortion clinics appears to decline, funding and political support for these facilities is also declining, putting the surgical abortion access that pill-ineligible patients need at serious risk. The lead researcher of the April 2025 CMAJ study explicitly cautioned that while medical abortion access had dramatically improved, the decline in local surgical abortion access from 22% to 18% of the Ontario population needed urgent attention, noting that “both are very important” and that the focus on pill access must not come at the expense of surgical care.
Canada Abortion by Age Group Statistics in 2026 | Demographics of Who Has Abortions 2023
Understanding who has abortions in Canada by age is central to directing both healthcare resources and policy. The 2023 CIHI data provides the most current national age breakdown available.
| Age Group | Abortions in 2023 (Canada) | Rate per 1,000 Women | Trend |
|---|---|---|---|
| 15–17 years | Smallest volume | 3.3 per 1,000 | Lowest rate of any age group |
| 18–24 years | Second-largest group | 14.9 per 1,000 | PMC study: +4.2/1,000 from mifepristone in Ontario |
| 25–29 years | ~25,677 — largest group | 18.4 per 1,000 | Consistently highest rate |
| 30–34 years | Second-largest by volume | 15.4 per 1,000 | Close behind 25–29 |
| 35–39 years | Meaningful volume | Lower | Rate grown over time |
| 40+ years | Lowest volume group | Lowest | Growing slowly |
| Women 25–29 as % of all abortions (2023) | ~25.3% | — | Largest single cohort |
| Women aged 18–29 combined (2023) | Majority | ~51% of all abortions | Consistent finding |
| Women aged 30+ (2023) | Significant share | ~47% | Rising vs historical baseline |
| Pre-2013 pattern (historical shift) | Women under 25 had highest rate | Changed by ~2013 | Now 25–29 dominant |
Source: CIHI, Induced Abortions Reported in Canada in 2023, March 20, 2025 (via Statista CIHI dataset, February 2026); We Need a Law analysis of CIHI 2023 data, April 2025; PMC “Trends in Abortion Rates in Ontario, Canada,” JAMA Network Open, April 2025; ARCC Statistics — Demographics of Abortion, updated June 2025
The 25–29 age group’s position as the most likely to have an abortion in Canada — at 18.4 per 1,000 women — and accounting for approximately 25,677 abortions in 2023 reflects a demographic reality that has shifted considerably over the past two decades. Before approximately 2013, women under 25 had the highest abortion rates — a pattern associated with the stereotypical image of a student or early-career woman facing an unintended pregnancy. What the current data shows is that the centre of gravity for abortion in Canada has moved into the late-20s and early-30s age range, reflecting a generation that is delaying childbearing into their 30s, completing education and establishing careers first, and making active reproductive decisions about whether and when to parent. The 30–34 rate of 15.4 per 1,000 is now very close to the 18–24 rate of 14.9 per 1,000 — these are not dramatically different groups in terms of abortion likelihood. What is particularly notable is that the rate for women over 35 is actually growing over time, from 3.9 to 5.6 per 1,000 since 2019 — a trend consistent with women continuing to seek reproductive autonomy later in life, often because a pregnancy is incompatible with their health, family circumstances, or existing parenting responsibilities.
The decline in abortion rates among under-25s over recent years is a genuine public health success that researchers have linked to a combination of factors: improved contraceptive access (including Ontario’s 2017 free prescription drug program for under-25s, B.C.’s 2023 universal free contraception policy, and the 2024 national free contraception framework), changing sexual behaviour patterns among younger Canadians, and possibly better sex education in some provinces. The PMC study published in April 2025 — examining all Ontario abortions from 2012 to 2022 — found that mifepristone availability from 2017 was associated with a rate increase of +4.2 per 1,000 among 20–24 year olds and essentially no change among 25–29 year olds compared to pre-mifepristone trends, suggesting that pill access specifically removed a barrier for the younger group. The broader pattern is one of abortion becoming more evenly distributed across women’s reproductive years, rather than being concentrated in any single life stage.
Canada Abortion Access by Province Statistics in 2026 | Service Availability 2024–2025
Access to abortion in Canada varies dramatically by province, city, and rural or urban location — and the gap between what the law permits and what geography delivers is the central equity challenge in Canadian reproductive healthcare.
| Province / Territory | Medical Abortion (Mifegymiso) | Surgical Abortion | Key Access Facts (2024–2025) |
|---|---|---|---|
| Ontario | Covered by OHIP; dispensed at pharmacies | Covered; hospital and clinic settings | Access rose 37% → 91% (2017–2022, CMAJ Apr 2025); surgical access declined 22% → 18% |
| Quebec | Covered; dispensed at pharmacies; midwives can prescribe | Extensive clinic network | Mifegymiso share only 17% in 2022 but jumped +80% in 2025 (CBC, Feb 12, 2026) |
| British Columbia | Covered; free contraception province-wide from 2023 | Covered | Elizabeth Bagshaw Clinic closed March 2025; Vancouver Coastal Health consolidating to single-provider model |
| Alberta | Covered; dispensed at pharmacies | Covered; Lancet study found access “minimally improved” in past decade | Slower mifepristone uptake vs Ontario |
| New Brunswick | Covered; >70% of all NB abortions in 2024 | Historically hospital-only; ban repealed Nov 7, 2024 by Premier Holt | Clinic 554 closed January 2024; still only 3 hospitals in 2 cities offering surgical abortion (Nov 2025) |
| Nova Scotia | Covered; universal coverage for Mifegymiso | Covered in hospitals | 4 surgical sites; up to 16 weeks |
| Prince Edward Island | Covered | Available; coordinated referral for later procedures | Surgical abortion available on island via Women’s Wellness Program; limited gestational range |
| Newfoundland and Labrador | Covered; universal coverage for Mifegymiso | Hospital-based | Remote/rural access remains challenging |
| Saskatchewan | Covered | More abortions in hospitals vs clinics (vs national average) | Hospital-dominant model |
| Manitoba | Covered | Available | Among highest provincial abortion rates nationally (CIHI data) |
| Territories (YK, NWT, NU) | Varies by territory | Limited; out-of-territory travel often required | Significant geographic barriers; remote communities underserved |
Source: CBC News NB abortion access November 6, 2025 and November 7, 2024; CBC News Elizabeth Bagshaw March 29, 2025; CMAJ Ontario access study, April 7, 2025; Global News Alberta access, April 7, 2025; CBC News Quebec Mifegymiso, February 12, 2026; Action Canada for Sexual Health and Rights, Abortion Services in Canada 2024; Health Canada, Abortion in Canada, canada.ca; ARCC Statistics, updated June 2025
The provincial breakdown of abortion access in Canada in 2026 is a study in contrasts. Ontario’s transformation is the clearest success story: in five years, the share of the population with a local abortion service went from 37% to 91% — a change almost universally attributed to pharmacies being allowed to fill Mifegymiso prescriptions without additional certification requirements. British Columbia introduced universal free contraception in 2023 and has strong abortion access in urban centres, yet the March 2025 Elizabeth Bagshaw closure — one of only three abortion clinics in Vancouver — shows how fragile surgical access infrastructure is even in the most abortion-supportive provinces. Vancouver Coastal Health’s move toward a “single provider, single site” model for reproductive care is intended to consolidate services rather than cut them, but the transition period creates genuine uncertainty. Abortion Care Canada’s decision to cut its direct client support program by 75% on April 1, 2025, reported alongside the Ontario CMAJ study coverage, is a further indicator of financial stress across the abortion care sector even as procedure volumes rise.
New Brunswick’s story from 2024 to 2026 is the most politically instructive in Canada. Clinic 554’s permanent closure on January 31, 2024 — after the previous government refused for years to fund non-hospital surgical abortions, in what critics called a direct violation of the Canada Health Act — was a decisive end to a decade-long political battle. Premier Susan Holt’s repeal of Regulation 84-20 on November 7, 2024, eliminating the ban on Medicare funding for non-hospital procedural abortions, was a historic policy reversal. Yet the CBC’s November 6, 2025 follow-up report confirmed that a full year later, “the same three hospitals are the only places where the service is offered, and doctors are showing less interest in providing the service.” Reproductive health researcher Martha Paynter noted: “The demand for procedural abortion is falling year over year” — with over 70% of all New Brunswick abortions now being handled by Mifegymiso — making the economics of standing up a new dedicated surgical clinic deeply challenging. The policy barrier is gone, but the structural barriers of demand, provider willingness, and facility investment remain.
Canada Abortion Safety and Complications Statistics in 2026 | Clinical Outcomes 2020–2023
Abortion is one of the safest medical procedures performed in Canada, and the clinical data fully supports that description. CIHI’s hospital-based complication data — which covers only a small share of all abortions, since most now occur outside hospitals — provides the best available benchmarks.
| Safety / Clinical Metric | Figure | Source / Year |
|---|---|---|
| Hospital abortions with no complications (2020) | ~97% | CIHI / Statista, 2020 hospital data |
| Hospital abortions resulting in hemorrhage (2020) | ~1% | CIHI hospital complication data, 2020 |
| Mifegymiso approved gestational limit (Health Canada) | 9 weeks (63 days) | Health Canada product monograph, standard |
| Ultrasound required for Mifegymiso prescription | Not required in most cases | Health Canada 2019 update; LMP and clinical history sufficient |
| Authorized prescribers — Mifegymiso | Physicians and Nurse Practitioners | Plus midwives in Quebec only |
| Telemedicine prescriptions for Mifegymiso | Available in multiple provinces | Virtual screening and prescribing permitted |
| CIHI gestational age data collection — hospitals | Discontinued after 2020 | CIHI noted it represented only small fraction of all abortions |
| Serious complications from safe legal abortion (Canada) | Rare; lower risk than continuing pregnancy | Standard medical consensus; WHO, SOGC |
| Hospital complications — method breakdown | Surgical higher complication rate than medical | Consistent with international evidence |
| Mifegymiso failure rate (requiring surgical completion) | Approximately 2–5% require follow-up procedure | Standard product monograph data; SOGC guidelines |
Source: CIHI, Induced Abortions Reported in Canada in 2020 (hospital complication data); Health Canada, Mifegymiso Product Monograph and Regulatory Updates; Society of Obstetricians and Gynaecologists of Canada (SOGC) Medical Abortion Guidelines; WHO Safe Abortion Technical and Policy Guidance; CIHI methodology note, March 20, 2025
The 97% complication-free rate for hospital abortions in 2020 — the most recent year for which CIHI collected and published complication data from hospitals — is consistent with decades of Canadian and international evidence confirming that abortion, when performed in regulated settings by trained providers, is significantly safer than carrying a pregnancy to term. CIHI discontinued gestational age and complication data collection from hospitals after 2020 because these procedures now represent only a small and declining proportion of all abortions in Canada; the majority take place in non-hospital settings that are not captured by CIHI’s complication tracking. This means the published complication data increasingly represents an unrepresentative sample — but the clinical consensus from the Society of Obstetricians and Gynaecologists of Canada (SOGC) and international evidence consistently confirms that both medical and surgical abortions at early gestational ages carry very low complication risks in qualified settings.
The Health Canada update in 2019 eliminating the mandatory ultrasound requirement for Mifegymiso prescriptions was a safety-neutral policy change that had significant access implications, particularly for remote and rural patients where ultrasound services may involve long waits or significant travel. The confirmation that gestational age can be determined through last menstrual period, clinical history, and physical examination when ultrasound is not readily available — in line with WHO guidelines — allowed family doctors and nurse practitioners in rural communities to begin offering medical abortion without requiring patients to travel to imaging services first. This change is one of several factors that contributed to the rapid rural uptake of Mifegymiso documented in Ontario research, where rural providers were actually found to have higher rates of medical abortion provision than urban ones after mifepristone became available. The approximately 2–5% of Mifegymiso cases requiring a follow-up surgical procedure to complete the abortion represents the most clinically significant complication of the pill method, and all providers and patients are counselled about this possibility before starting treatment.
Canada Abortion Access Gaps and Recent Policy Changes in 2026 | Clinics, Funding, and Legal Updates 2024–2025
The most significant developments in Canadian abortion access in 2024 and 2025 are a mix of policy breakthroughs, clinic closures, and funding pressures that are reshaping the service landscape in real time.
| Development | Date | Province | Impact |
|---|---|---|---|
| Clinic 554 (Fredericton) permanent closure | January 31, 2024 | New Brunswick | NB’s only non-hospital surgical abortion clinic closed; cited lack of Medicare funding and rent increase |
| NB Regulation 84-20 repealed — ban on non-hospital surgical abortion funding eliminated | November 7, 2024 | New Brunswick | Historic policy change by Premier Holt; allows Medicare to fund non-hospital procedural abortions |
| One year later — NB access unchanged | November 6, 2025 | New Brunswick | Still only 3 hospitals in 2 cities offering surgical abortion; no new clinics (CBC, Nov 6, 2025) |
| Elizabeth Bagshaw Clinic (Vancouver) closure announced | March 29, 2025 | British Columbia | 35-year-old clinic closing; funding uncertainty and VCH consolidation plan cited |
| Vancouver Coastal Health consolidation plan | 2025 | British Columbia | Moving to “single provider, single site” model for reproductive care across Elizabeth Bagshaw, Everywoman’s Health, and Willow Clinic |
| Abortion Care Canada — direct client support cut 75% | April 1, 2025 | National | Significant reduction in direct support services for patients navigating access barriers |
| Quebec Mifegymiso prescriptions +80% increase | 2025 vs 2024 | Quebec | 2,852 reimbursed in 2025 vs 1,586 in 2024 (CBC, February 12, 2026; RAMQ data) |
| B.C. free contraception policy | 2023 (ongoing) | British Columbia | Universal coverage for all provincially insured residents; ongoing impact on abortion demand |
| National free contraception policy framework | 2024 (implementation ongoing) | Federal / All provinces | Bilateral federal–provincial agreements to provide free contraception nationally |
| Alberta — abortion access “minimally improved” in past decade | Published 2024 | Alberta | Lancet study finding; slower uptake of Mifegymiso vs Ontario model |
Source: CBC News, “Clinic 554 to close,” January 31, 2024; CBC News, “Holt government repeals ban,” November 7, 2024; CBC News, “N.B. abortion access a work in progress,” November 6, 2025; CBC News, “Vancouver abortion clinic to close after 35 years,” March 29, 2025;
The policy and infrastructure developments of 2024–2025 tell a story of simultaneous progress and fragility. On the progress side: New Brunswick’s November 2024 repeal of its long-standing ban on non-hospital abortion funding was genuinely historic — ending a policy that Canada’s own federal government had repeatedly cited as a likely Canada Health Act violation. Quebec’s 80% jump in Mifegymiso prescriptions in 2025 confirms that years of restrictive prescribing practices by the College des Médecins are finally giving way to the kind of broad primary care uptake seen in Ontario and New Brunswick. The 2024 national free contraception framework — which committed the federal government to bilateral agreements with provinces ensuring prescription contraception is available at no cost nationwide — addresses one of the most consistent upstream drivers of unintended pregnancy.
On the fragility side: two significant surgical abortion clinics closed in Canada in 2024–2025 — Clinic 554 in January 2024 and the Elizabeth Bagshaw Clinic in Vancouver in spring 2025 — and Abortion Care Canada cut its direct patient support services by 75% in April 2025 due to funding constraints. These closures happen precisely as the CMAJ study data shows surgical abortion access already declining from 22% to 18% of the Ontario population even before either closure. The researchers’ warning that both medical and surgical access must be maintained — that improved pill access does not make surgical care less essential for patients who are beyond 9 weeks, or for whom medication abortion is contraindicated — lands in a policy environment where funding flows are not reliably matching that dual priority. The NB experience is the clearest warning: even after a historic legal barrier is removed, without direct investment in provider training, fee structures, and facility support, the practical reality of access does not automatically improve. One year later, the same three hospitals in two cities are still the only places in all of New Brunswick where a patient can get a publicly funded surgical abortion.
Disclaimer: The data reports published on The Global Files are sourced from publicly available materials considered reliable. While efforts are made to ensure accuracy, no guarantees are provided regarding completeness or reliability. The Global Files is not liable for any errors, omissions, or damages resulting from the use of these reports.